Sector | Finance | Compare with Sector peers |
Industry | Finance - Others | Compare with Industry peers |
Website | http://www.biogenpharma.shop | |
Market Cap | 74.40 Cr. | |
Enterprise Value(EV) | 79.90 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 0.02 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | 75.00 | Trailing Twelve Months Ending 2023-12 |
Industry PE | 50.06 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | 0.85 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | 1.33 | Calculated using Price: 1.14 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 65.26 Cr. | 652,603,000 Shares |
FaceValue | 1 | |
About Biogen Pharmachem Industries Ltd. | ||
Sun Techno Overseas Ltd., formerly Wellworth Overseas Limited, is an India-based company.In 2011 the company changed its name from Wellworth Overseas Ltd. to Sun Techno Overseas Ltd. |
1 Day |
|
-1.72% |
1 Week |
|
-4.20% |
1 Month |
|
|
3 Month |
|
-25.97% |
6 Month |
|
+46.15% |
1 Year |
|
+67.65% |
2 Year |
|
-23.49% |
5 Year |
|
+442.86% |
10 Year |
|
+356.00% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | -0.22 | -0.05 | -0.2 | -11.4 | -0.01 | -0.21 | -2.92 | -0.02 | 0.84 | |
Return on Capital Employed (%) | -0.14 | -0.04 | -0.19 | -11.33 | -0.01 | -0.21 | -2.91 | -0.02 | 0.84 | |
Return on Assets (%) | -0.13 | -0.04 | -0.18 | -11.01 | -0.01 | -0.21 | -2.91 | -0.02 | 0.83 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 61 | 61 | 61 | 54 | 54 | 56 | 54 | 54 | 55 | 56 | |
Non Curr. Liab. | 9 | 8 | 2 | 2 | 2 | 0 | 6 | ||||
Curr. Liab. | 3 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | |
Minority Int. | |||||||||||
Equity & Liab. | 73 | 69 | 63 | 56 | 58 | 56 | 54 | 55 | 55 | 62 | |
Non Curr. Assets | 45 | 55 | 63 | 49 | 50 | 48 | 52 | 53 | 55 | 61 | |
Curr. Assets | 29 | 14 | 0 | 7 | 8 | 8 | 3 | 2 | 0 | 0 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 73 | 69 | 63 | 56 | 58 | 56 | 54 | 55 | 55 | 62 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 1 | 2 | 2 | 1 | |||||||
Other Income | 0 | 0 | 1 | 1 | |||||||
Total Income | 0 | 1 | 2 | 2 | 1 | 2 | |||||
Total Expenditure | 0 | 0 | 0 | -7 | -1 | 0 | -3 | -2 | 0 | -1 | |
PBIDT | 0 | 0 | 0 | -7 | 0 | -2 | 0 | 0 | 1 | ||
Interest | |||||||||||
Depreciation | |||||||||||
Taxation | |||||||||||
Exceptional Items | |||||||||||
PAT | 0 | 0 | 0 | -7 | 0 | -2 | 0 | 0 | 1 | ||
Adjusted EPS | 0 | 0 | 0 | 0 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | -7 | 5 | 0 | -14 | 0 | -1 | 4 | 1 | 2 | |
Cash Fr. Inv. | -9 | 17 | 17 | 4 | 14 | -1 | 2 | -4 | -1 | -2 | |
Cash Fr. Finan. | 10 | -11 | -22 | -4 | -1 | 1 | 0 | 0 | |||
Net Change | 1 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | |||
Cash & Cash Eqvt | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Fri, 29 Mar 2024
Closure of Trading Window Intimation of Closure of Trading Window for considering the Audited Financial Results of the company for the Quarter and Year ended on 31.03.2024 |
Tue, 13 Feb 2024
Un-Audited Financial Result Quarter Ended On 31St December 2023 Pursuant To Regulation 33 Of The SEBI (LODR) Regulations 2015. PFA |
Thu, 01 Feb 2024
Shareholder Meeting / Postal Ballot-Outcome of EGM PFA |
Fri, 19 Apr 2024 |
Opening at Low |
Closing Below Previous Low |
High Increase in 1 Month |
High Decrease in 3 Months |
High Increase in 6 Months |